Fundraising FoxSensars
Lausanne, CH · 1 known investors
Find your way into Sensars
Sign up to see every warm intro you have to Sensars
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sensars team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sensars develops an implantable neurostimulation system that restores sensory feedback to the limbs by interfacing a proprietary intra-nerve electrode array with sensory nerve fibers, paired with wearable sensor insoles. The technology targets diabetic neuropathy and limb loss to reduce complications such as ulcers, falls, and amputations.
Founders & leadership
FM
Francesco M PetriniCo-founder and CEO of Sensars, a neurotechnology company developing implantable nerve interfaces to restore sensory feedback in limbs. Petrini holds research and development experience from EPFL, ETH Zurich, and Imperial College London, with 15+ years of work in neuroprosthetics and neuromodulation, and has authored numerous peer-reviewed publications in neuroscience and biomedical engineering.
GS
TE
Todd E. HauserCFO
Investors · 1
Related companies · 3
Sense Neuro DiagnosticsSense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.
RxFunctionRxFunction develops Walkasins, a wearable lower limb sensory prosthesis that replaces lost nerve function for detecting and signaling foot pressure. It is intended for patients with peripheral neuropathy who have gait and balance impairments and are at high risk of falls.
Neuspera Medical, Inc.Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder. Its device is powered by a discreet, wirelessly charged external battery worn daily, targeting patients—particularly women in the U.S.—affected by these conditions.
Companies working in the same space as Sensars.
Frequently asked questions
- What does Sensars do?
- Sensars develops an implantable neurostimulation system that restores sensory feedback to the limbs by interfacing a proprietary intra-nerve electrode array with sensory nerve fibers, paired with wearable sensor insoles. The technology targets diabetic neuropathy and limb loss to reduce complications such as ulcers, falls, and amputations.
- Who founded Sensars?
- Sensars was founded by Francesco M Petrini, Guy Siman.
- Who are Sensars's investors?
- Sensars's investors include Health Wildcatters.
- Where is Sensars headquartered?
- Sensars is headquartered in Lausanne, CH.